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What is already known about this subject? 
• Short sleep duration and poor sleep quality are associated with increased body fat. 
• Body mass index and waist circumference are poor measures of fat deposition in 
different compartments. 
 
What does this study add? 
• Short sleep duration and poor sleep quality are associated with a higher amount of 
visceral adipose tissue in men and women, but this association disappeared after 
adjustment for total body fat. 
• Short sleep duration and poor sleep quality are not specifically associated with a 






Objective: To investigate the associations of sleep duration and sleep quality with visceral 
adipose tissue (VAT) in middle-aged individuals. 
Methods: In this cross-sectional analysis of baseline measurements of the Netherlands 
Epidemiology of Obesity study, participants underwent anthropometry and completed the 
Pittsburgh Sleep Quality Index (PSQI) for assessing short sleep duration (as sex-specific age-
adjusted percentiles) and poor quality (PSQI>5). VAT was assessed by magnetic resonance 
imaging in a random subgroup. We performed linear regression analyses to examine 
associations of short sleep and poor sleep with measures of body fat, adjusted for 
confounding including total body fat in models with VAT.  
Results: A total of 5,094 participants (52% women; mean [SD] age of 56 [6] years), of whom 
1,947 with VAT, were analyzed. The difference in VAT between poor sleep (PSQI>5) 
compared to good sleep (PSQI≤5) was 7.2 (95%CI:1.2, 13.8) cm2 in women and 16.1 
(95%CI:6.2, 26.0) cm2) in men. These differences attenuated toward the null after the 
adjustment for total body fat. Similar patterns of associations were observed for short sleep 
(lowest 10% as compared to median 60%). 
Conclusions: Our results suggest that measures of sleep are not specifically associated with a 





Obesity, in particular abdominal obesity, is a well-established risk factor for 
metabolic and cardiovascular diseases (1). Multiple factors have thus far been identified to 
contribute to the risk of obesity. In addition to well-known determinants for obesity as a 
sedentary lifestyle and high caloric intake, broad consensus has been reached in just a few 
years that short total sleep time and poor sleep quality are associated with a higher body mass 
index (BMI) (2, 3, 4, 5, 6, 7, 8, 9, 10). In addition, some of these studies observed an 
association between long total sleep time and BMI as well, which suggests that there could be 
a U-shaped relation between total sleep time and BMI (3, 6). The hypothesis of a short 
habitual sleep duration leading to higher body fat is supported by intervention studies. For 
example, sleep curtailment causes a change in circulating ghrelin and leptin concentrations, 
hormones essential for sensing hunger and satiety (11, 12). Even one night of sleep 
curtailment causes leptin levels and feeling of satiety to decrease, and ghrelin levels to 
increase, subsequently increasing the feeling of hunger.  
Abdominal adiposity is characterized by storage of excess fat in the abdominal 
subcutaneous and visceral adipose tissue (VAT). In particular, VAT has been shown to be a 
strong risk factor for diseases like type 2 diabetes mellitus and cardiovascular diseases (5, 13, 
14, 15, 16). Because direct assessment of VAT by magnetic resonance imaging is not widely 
available in large cohort studies, studies often investigated the association between sleep 
duration and waist circumference, as a measure of abdominal adiposity and a proxy of VAT 
(3, 4, 5, 17). These studies observed that short sleep duration, and not long sleep duration, 
was associated with a larger waist circumference. The association between poor sleep quality 
and waist circumference is less well studied, but available literature suggests that poor sleep 
quality is associated with a higher waist circumference (18, 19).  
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Waist circumference, however, does not distinguish abdominal subcutaneous fat from 
visceral fat. Given that VAT is a strong risk factor for insulin resistance (5, 13, 14, 15, 16), 
and different measures of habitual sleep have been associated with insulin resistance and type 
2 diabetes mellitus (20, 21, 22), we hypothesized that short sleep duration as well as poor 
sleep quality are specifically associated with a higher amount of VAT. Therefore, the aim of 
this study was to investigate the associations of sleep duration and sleep quality with VAT in 





Study design and study population 
The present study is a cross-sectional analysis of baseline measurements of the Netherlands 
Epidemiology of Obesity (NEO) study, a population-based, prospective cohort study. The 
NEO study started in 2008 and included 6,671 individuals aged 45–65 years, with an 
oversampling of individuals with overweight or obesity. The study design and population is 
described in detail elsewhere (23). Men and women living in the greater area of Leiden (in 
the West of the Netherlands) were invited to participate if they were aged between 45 and 65 
years and had a self-reported BMI of 27 kg/m2 or higher. In addition, all inhabitants aged 
between 45 and 65 years from one municipality (Leiderdorp) were invited to participate 
irrespective of their BMI, allowing for a reference group with a normal BMI distribution. The 
Medical Ethical Committee of the Leiden University Medical Center (LUMC) approved the 
design of the study. All participants gave their written informed consent.  
Participants were invited for a baseline visit at the NEO study centre of the LUMC. 
Prior to the study visit, participants completed a general questionnaire at home to report 
demographic, lifestyle and clinical information. Collection of data from the Pittsburgh sleep 
quality index (PSQI) questionnaire only started as from July 2009. For this reason, 
participants (N = 1,402) included before July 2009 without PSQI data were not included in 
the present study. The participants were asked to bring all medication they were using to the 
study visit for a medication inventory. 
At the study site, a screening form was completed by all participants asking about 
anything that might create a health risk or interfere with MRI imaging (most notably metallic 
devices, claustrophobia, and a body circumference of more than 1.70 m). Of the participants 
who were eligible for MRI, approximately 35% of the total study population were randomly 
selected to undergo direct assessment of VAT. 
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Of the participants with PSQI data, participants with missing data on either waist 
circumference or total body fat (TBF) (n=30) or covariates (n=145) were excluded from the 
analyses. For the analyses on VAT, only participants with a measurement of VAT were 
included (n=1,947). 
 
Assessment of sleep quality and duration 
To assess sleep duration, we made use of the question related to this topic on the Pittsburgh 
sleep quality index (PSQI) questionnaire: “During the past month, how many hours of actual 
sleep did you get at night. To facilitate the interpretation of the observations whether there is 
a non-linear (e.g., U-shape) relationship between sleep duration and measures of adiposity, 
we studied the associations between sleep duration and measures of adiposity in different 
strata based on sleep duration. Because there is no consensus in the literature to define short 
and long total sleep time (2, 3, 4, 5, 6, 7, 8, 9, 10, 17), and defining groups of participants 
based on the sleep duration could be misclassified because of age and sex, we standardized 
sleep durations based on the residuals, adjusted for age and stratified by sex. Based on 
percentiles of these residuals, we defined the shortest sleepers (0-10 percentile), short 
sleepers (10-20 percentile), middle sleepers (20-80 percentile, reference group), long sleepers 
(80-90 percentile) and the longest sleepers (90-100 percentile). 
Sleep quality was based on the total PSQI score, which ranges from 0 to 21. A score 
of ≤5 is considered good sleep quality, whereas a score of >5 is considered poor sleep quality 
(24). In addition, we defined participants with a PSQI score of ≥8 as worse sleep quality.  
 
Measures of body fat 
Body weight and percent body fat were measured by the Tanita bio impedance balance (TBF-
310, Tanita International Division, UK) without shoes and one kilogram was subtracted to 
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correct for the weight of clothing. Height was measured without shoes with a vertically fixed, 
calibrated tape measure. BMI was calculated by dividing the weight in kilograms by the 
height in meters squared. Waist circumference was measured with a horizontally placed tape 
measure mid-way between the lower costal margin and the iliac crest with a precision of 0.1 
cm. 
Abdominal subcutaneous and visceral fat were quantified by a turbo spin echo 
imaging protocol using MRI in 1,947 participants with exposure and covariate data. Imaging 
was performed on a 1.5 Tesla MR system (Philips Medical Systems, Best, the Netherlands). 
The VAT depots was quantified by converting the number of pixels to square cm for all three 
slides using in-house-developed software (MASS, Medis, Leiden, the Netherlands). At the 
level of the 5th lumbar vertebra three transverse images each with a slice thickness of 10 mm 
were obtained during a breath-hold. The mean of VAT from the three slices was calculated 
and used in the analyses. 
 
Covariates 
Based on questionnaires, participants reported ethnicity by self-identification in eight 
categories which we grouped into white and other. Tobacco smoking was reported in the 
three categories: current smoker, former smoker, or never smoker. Highest level of education 
was reported in 10 categories according to the Dutch education system and participants with 
none, primary school or lower vocational education were categorized as lower educated and 
the others as higher educated. Alcohol and coffee consumption were self-reported on a food 
frequency questionnaire. Alcohol consumption was expressed in grams of alcohol per day 
and coffee consumption as cups per day. Participants reported the frequency, duration and 
intensity of their usual physical activity during leisure times using the Short Questionnaire to 
Assess Health-enhancing physical activity (SQUASH) (25, 26). For this questionnaire, 
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participants reported the frequency and duration of their physical activity during leisure time 
and this was expressed in hours per week of metabolic equivalents. Menopausal status was 
divided into three categories (pre-, peri-, and postmenopausal) based on information on 
oopho- or hysterectomy and/or self-reported menopausal status. Women who reported a 
hysterectomy were classified according to their age (premenopausal when <46 years, peri-
menopausal when 46 to 55 years, and postmenopausal when ≥55 years). Women who did not 
report menopausal status and were 58 years or older were classified as postmenopausal. Use 
of hormones (hormone replacement therapy and oral contraceptives) and of sleep medication 
was based on a medication inventory. 
 
Statistical analysis 
In the NEO study, persons with a BMI of 27 kg/m2 or higher are oversampled. To correctly 
represent associations for the general population (27), adjustments for the oversampling of 
participants with a BMI ≥ 27 kg/m2 are made. This is done by weighting individuals towards 
the BMI distribution of participants from the Leiderdorp municipality (28), whose BMI 
distribution was similar to the BMI distribution of the general Dutch population (29). All 
results are based on weighted analyses. Consequently, the results apply to a population-based 
study without oversampling of individuals with a BMI ≥27 kg/m2. All analyses are 
performed using STATA version 12.1 (StataCorp LP, TX, US).  
Baseline characteristics of the study population were expressed as mean (with 
standard deviation [SD]), median (inter quartile range [IQR]) or proportion (%), in the whole 
study population and separately for men and women (Table 1). Given the known differences 
in body fat distribution and habitual sleep between men and women, all analyses were 
performed separately for men and women. In the first analyses, we aimed to confirm well-
established associations between short habitual sleep duration and poor sleep quality and 
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BMI, waist circumference and total body fat in the total study population (2, 3, 4, 5, 6, 7, 8, 9, 
10). Subsequently, we repeated these analyses for the subpopulation of participants who 
underwent MRI, and investigated the association between short habitual duration and poor 
sleep quality and VAT. To examine the associations between sleep duration and the measures 
of adiposity, we performed multivariable linear regression analyses. We calculated the mean 
difference in adiposity measure in the sleep duration groups and sleep quality groups 
compared with the reference groups (20-80% middle sleep duration and PSQI≤5) with 
corresponding 95% confidence intervals. We adjusted crude models for age, physical activity, 
menopausal state, ethnicity, alcohol consumption, coffee consumption, smoking, education 
and the use of oral contraceptives and hormone replacement therapy (ATC-code: G03A, 
G03C, G03F). The models of sleep duration were additionally adjusted for sleep medication 
(ATC-code: N05C) use. We additionally performed joint models and adjusted the analyses of 
sleep duration for sleep quality and vice versa to provide insights on the relative contributions 
of these two measures of habitual sleep to the measures of adiposity. We adjusted the 
analyses concerning VAT for TBF to investigate to what extent associations were specific for 
VAT instead of merely a reflection of associations with overall adiposity. Finally, we tested 
whether the associations between habitual sleep and measures of adiposity were different 
between men and women by including an interaction term between sex and the measure of 




Characteristics of the study population 
A total of 5,094 participants completed the PSQI-questionnaire and had complete data on 
potential confounding factors. Of these, VAT was assessed in 1,947 participants. In the total 
study population (54% women) (Table 1), mean (SD) age was 55.7 (6.0) years.  
Mean (SD) sleep duration was 7.1 (1.0) hours in women and 6.9 (1.0) hours in men. 
PSQI score had a median (IQR) of 5 (3, 7) in women and 4 (2, 5) in men. Whereas women 
had more total body fat than men, men had a larger waist circumference and more VAT than 
women. The characteristics of the subpopulation with VAT assessment were similar to the 
total study population (Supplement Table 1). 
 
Associations between sleep duration and measures of adiposity 
Compared with the reference population (Table 2), we observed that both in men and women 
the group of the shortest sleepers had a higher BMI (mean difference [95% confidence 
interval] in women 1.9 [1.0, 2.9] kg/m2; in men 1.3 [0.6, 2.0] kg/m2), larger waist 
circumference (women 4.2 [1.6, 6.8] cm, men 3.9 [1.9, 6.0] cm) and more TBF (women 2.3 
[0.9, 3.6] %, men 1.7 [0.6, 2.9] %). These results did not materially differ when we adjusted 
for potential confounding factors. Additional adjustment for sleep quality only slightly 
attenuated the associations (results not shown). Compared with the reference population, 
short, long and longest sleep were not associated with BMI, waist circumference or TBF. We 
observed similar associations for BMI, waist circumference and TBF in the subpopulation of 
participants who underwent MRI (Supplementary Table 2). 
Compared with the reference group (Figure 1), the shortest sleep group had more 
VAT (women 16.4 [3.1, 29.8] cm2, men 10.2 [-4.1, 24.2] cm2). However, additional 
adjustment of the associations for TBF, attenuated the estimates for shortest sleep duration 
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towards the null (women 6.4 [-1.4, 14.1] cm2, men 0.6 [-10.8, 12.0] cm2). No evidence was 
observed for differences between men and women (P-value for interaction > 0.05). 
 
Associations between sleep quality and measures of adiposity 
Table 3 shows the mean differences in BMI, waist circumference and TBF associated with 
the sleep quality groups (poor sleep quality PSQI >5; worse sleep quality PSQI ≥8) compared 
with the reference group (PSQI≤5). In crude models, poor sleep quality was associated with 
higher BMI (women 0.8 [0.4, 1.2] kg/m2, men 0.7 [0.3, 1.2] kg/m2), larger waist 
circumference (women 1.8 [0.6, 3.1] cm, men 2.5 [1.2, 3.8] cm) and more TBF (women 1.1 
[0.4, 1.8] %, men 1.1 [0.4, 1.8] %). In line, worse sleep quality (PSQI ≥8) was associated 
with higher BMI (women 1.1 [0.6, 1.6] kg/m2, men 0.8 [0.1, 1.4] kg/m2), larger waist 
circumference (women 2.7 [1.1, 4.2] cm, men 2.6 [0.7, 4.4] cm) and more TBF (women 1.7 
[0.8, 2.5 ]% , men 1.3 [0.3, 2.3] %). These associations attenuated after adjustment for 
potential confounding factors. Additional adjustment for sleep duration did not notably 
change the associations (results not shown). We observed similar associations for BMI, waist 
circumference and TBF in the subpopulation of participants who underwent MRI 
(Supplementary Table 3).  
Compared with normal sleep (PSQI ≤5), poor sleep quality was associated with more 
VAT in men (17.5 cm2 [7.2, 27.8]) and women (7.5 cm2 [1.2, 13.8]); estimates did not 
materially change after adjustment for potential confounding factors with the exception of 
TBF (Figure 2). Associations of worse sleep were in similar direction as compared with 
normal sleep, although with larger confidence intervals (women 9.3 cm2 [1.2, 17.4]; men 9.1 
cm2 [-3.5, 21.8]). After additional adjustment for TBF the associations attenuated toward the 
null (poor quality: women -1.4 [-5.9, 3.1] cm2, men 6.5 [-1.6, 14.5] cm2; worse quality: 
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women -2.2 [-7.9, 3.5] cm2, men 2.3 [-6.7, 11.2] cm2) (Figure 2). No evidence was observed 





In the present population-based study of middle-aged men and women, we observed that 
short sleep duration and poor sleep quality were associated with measures of overall and 
abdominal adiposity, but we did not observe a clear dose-response relationship between sleep 
quality and abdominal adiposity. However, associations of sleep quality and duration with 
visceral fat disappeared after adjustment for TBF. These results suggest that, although 
measures of sleep were associated with TBF and other measures of overall adiposity, short 
habitual sleep duration and quality were not specifically associated with VAT. These results 
were similarly observed for men and women.  
The observed associations with BMI, waist circumference and TBF are consistent 
with other observational studies, showing that short sleep duration and poor sleep quality are 
associated with having more body fat (2, 3, 4, 5, 6, 7, 8, 9, 10). Besides the observation that 
men and women have different sleeping habits (women tend to sleep longer, and have a 
higher risk of experiencing insomnia during their lifespan, and 33-51% of women report 
sleep complaints during menopausal transition (30)), and have a different body fat 
distribution, the observed associations of sleep duration and sleep quality with adiposity were 
similar in men and women. The observation that the association of short sleep duration and 
poor sleep quality with VAT attenuated after adjustment for TBF, is in line with a cross-
sectional study performed in a Japanese population (31). In 5,400 Japanese men with self-
reported sleep data, and computed tomography data to determine body fat depots, short sleep 
duration was associated with higher BMI, waist circumference, abdominal subcutaneous 
adipose tissue and VAT. However, when the association with VAT was adjusted for 
abdominal subcutaneous adipose tissue, this association disappeared, which is consistent with 
our findings. While we observed an association between short sleep duration and adiposity in 
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both men and women, there was no association in Japanese women, although this discrepance 
in results could also be due to a limited sample size (n=642) (31).  
Our results suggest that a habitual short sleep duration and poor sleep quality are 
associated with general adiposity rather than abdominal adiposity. A possible reason for the 
lack of an association between sleep and VAT independent of total body fat could be either 
explained by a too low number of individuals classified as short sleeper or that the 
association between sleep measures and VAT does not exist independent of overall adiposity. 
Furthermore, the group classified as short sleepers reported a sleep duration ranging between 
1.7 and 5.7 hours. However, as there is no consensus about the definition of short sleep (2, 3, 
4, 5, 6, 7, 8, 9, 10, 17), we are not able to determine whether the total sleep duration in this 
group is sufficiently short to observe any associations. Unlike some of the previous studies 
(3, 6), we did not observe a U-shape between sleep duration and adiposity in this population. 
One potential explanation could be that sleep was not sufficiently long in the percentiles 
which we defined as long sleep (sleep duration in the upper percentile ranged between 8 and 
13 hours). Although we classified the highest percentile as long sleep duration; the sleep 
duration reported by this group still only ranged between 8.0 and 13.0 hours. As there is no 
consensus about the definition of long sleep (2, 3, 4, 5, 6, 7, 8, 9, 10, 17), it is unclear whether 
this group includes a sufficient number of long sleepers. Also, the majority of the other 
studies did not observe a U-shape (2, 4, 5, 7, 8, 9, 10). Therefore, it is possible that the few 
(smaller) studies that observed this U-shape found a false-positive association between long 
sleep and increased adiposity.  
One of the strengths of our study is the direct assessment of visceral fat with MRI (32) 
in a relatively large study population. A limitation of this study is its cross-sectional and 
observational design. As a result, we cannot draw conclusions on the direction and causality 
of the associations between measures of sleep and adiposity. In literature, evidence for both 
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directions is described. It has been shown that even one night of sleep deprivation can lead to 
decreased leptin levels, and increased ghrelin levels, which subsequently increase appetite 
(11, 12). Furthermore, a recent genome-wide association study on different measures of 
habitual sleep found a shared genetic component of insomnia symptoms and obesity risk (33). 
However, obesity has also been described as an important risk factor for multiple sleeping 
disorders, which includes sleep apnea (34, 35). Another limitation is that sleep data was self-
reported, and objective sleep measurements with actigraphy or polysomnography may be 
more reliable methods to assess sleep duration and quality. Other studies have investigated 
the association between objective sleep measures and adiposity. For example, Moraes et 
al.(4) used both actigraphy and polysomnography to assess sleep duration. Also they 
observed an association between short sleep duration, measured by both actigraphy and 
polysomnography, and increased adiposity. And last, this study was done in a study 
population predominantly of European ancestry. For this reason, our results need to be 
confirmed in populations of different ancestry backgrounds. However, in the Multi-Ethnic 
Study of Atherosclerosis (MESA) study short sleep duration (<6 hours) was associated with 
higher BMI, waist circumference and TBF, also after adjustment for race, and there was no 
evidence for effect modification by race (10).  
Taken together, both short sleep duration and poor sleep quality are associated with 
more overall body fat in middle-aged men and women and these associations were not 
specific for VAT. The previously observed associations between disturbances in measures of 
habitual sleep (e.g., short sleep duration, poor sleep quality) and insulin resistance and type 2 
diabetes mellitus (20, 21, 22) is therefore not likely to be specifically affected by higher 
amounts of VAT in individuals with short sleep duration and poor sleep quality. Future 
prospective studies should investigate the direction of the associations between sleep duration 
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Figure 1: Associations between sleep duration and VAT in 1947 participants in the NEO 
study aged between 45 and 65 years. 
Results were based on analyses weighted towards the BMI distribution of the general 
population (n=1947; 1032 men, 915 women). Results van be interpreted as the mean 
difference (with 95% confidence interval) in VAT (in cm2) between the index and reference 
group. Model 1, crude model. Model 2, adjusted for age, physical activity, education, 
ethnicity, alcohol consumption, coffee consumption, and smoking. Model 3, Model 2 + total 
body fat. Models 2 and 3 in women were additionally adjusted for menopausal status and the 
use of hormones.  
 
Figure 2: Associations between sleep quality and VAT in 1947 participants in the NEO 
study aged between 45 and 65 years. 
Results were based on analyses weighted towards the BMI distribution of the general 
population (n=1947; 1032 men, 915 women). Results van be interpreted as the mean 
difference (with 95% confidence interval) in VAT (in cm2) between the index and reference 
group. Model 1, unadjusted for potential confounding factors. Model 2, adjusted for age, 
physical activity, education, ethnicity, alcohol consumption, coffee consumption, and 
smoking. Model 3, Model 2 + total body fat. Models 2 and 3 in women were additionally 




Table 1: Characteristics of the participants in the Netherlands Epidemiology of Obesity study, 
and stratified by sex. 






Age (years), mean (SD) 56 (6) 55.5 (6) 56 (6) 
BMI (kg/m2), mean (SD) 26.0 (4) 25.6 (5) 27 (4) 
Total body fat (%),mean (SD) 31 (9) 36.4 (7) 25 (6) 
Waist circumference (cm), mean (SD) 91 (13) 86 (13) 98 (11) 
VAT (cm2) (n=1947), median (SD) 76 (47, 116) 54 (36, 84) 101 (73, 140) 
Total sleep duration (hours/night), mean (SD) 7 (1) 7 (1) 7 (1) 
Pittsburgh score, median (IQR) 4 (3, 6) 5 (3, 7) 4 (2, 5) 
Education (high a), % 47 ± 1.4 45 ± 1.9 49 ± 2.0 
Ethnicity (white), % 95 ± 0.6 95 ± 0.8 95 ± 0.9 
Alcohol consumption (grams/day), median (IQR) 10 (3, 21) 8 (2, 15) 17 (6, 28) 
Physical activity (MET-hours/week), median (IQR) 30 (16, 50) 30 (17, 49) 31 (16, 51) 
Coffee consumption b, % 
  0 cups/day 
  >0-4 cups/day 
  >4 cups/day 
 
5 ± 0.6 
61 ± 1.3 
34 ± 1.3 
 
7 ± 1.0 
68 ± 1.8 
25 ± 1.7 
 
2 ± 0.6 
52 ± 2.0 
46 ± 2.0 
Smoking, % 
  Current 
  Former 
 
16 ± 1.0 
45 ± 1.4 
 
15 ± 1.4 
44 ± 1.9 
 
18 ± 1.5 
46 ± 2.0 
Use of hypnotics and sedatives, %  4 ± 0.5 5 ± 0.8 2 ± 0.6 
Hormone use c, % 
  Current 
  Former 
  
10 ± 1.1 




Post-menopausal state, %  60 ± 1.9 - 
Results were based on analyses weighted towards the BMI distribution of the general 
population (n=5094; 2449 men and 2645 women). Data are shown as mean (SD), median 
(IQR) or percentage ± 95% confidence interval for measurement dispersion. 
BMI: Body Mass Index; NEO: Netherlands Epidemiology of Obesity; VAT: visceral adipose 
tissue; MET: metabolic equivalent. 
a High education: higher general secondary education, pre-university education, higher 
vocational education, university. 
b Coffee cup defined as 125 ml/cup. 
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Table 2: Associations between sleep duration and BMI, WC and TBF in 5094 participants in the NEO study aged between 45 and 65 years 
 Shortest sleep 
(0-10%) 
Men = 1.7-5.7 hrs 
Women = 2.5-5.4 hrs 
Short sleep 
(10-20%) 
Men = 5.7-6.0 hrs 
Women = 5.4-5.9 hrs 
Reference 
(20-80%) 
Men = 6.0-7.7 hrs 
Women = 5.9-7.9 hrs 
Long sleep 
(80-90%) 
Men = 7.7-8.0 hrs 
Women = 7.9-8.0 hrs 
Longest sleep 
(90-100%) 
Men = 8.0-13.0 hrs 
Women = 8.0-12.9 hrs 
Body mass index (kg/m2)      
  Men, model 1 1.3 (0.6, 2.0) -0.1 (-0.7, 0.6) - 0.2 (-0.5, 0.8) -0.2 (-0.8, 0.6) 
  Men, model 2 1.2 (0.5, 1.8) -0.1 (-0.7, 0.5) - 0.2 (-0.4, 0.9) -0.4 (-1.1, 0.3) 
  Women, model 1 1.9 (1.0, 2.9) 0.5 (-0.3, 1.3) - 0.2 (-0.5, 0.9) 0.2 (-0.5, 1.1) 
  Women, model 2 1.6 (0.7, 2.6) 0.4 (-0.4, 1.2) - 0.1 (-0.7, 0.8) 0.2 (-0.6, 1.0) 
      
Waist circumference (cm)      
  Men, model 1 3.9 (1.9, 6.0) -0.2 (-2.2, 1.7) - 0.4 (-1.6, 2.4) 0.0 (-2.1, 2.1) 
  Men, model 2 3.4 (1.5, 5.4) -0.5 (-2.5, 1.4) - 0.7 (-1.2, 2.5) -0.6 (-2.6, 1.4) 
  Women, model 1 4.2 (1.6, 6.8) 1.8 (-0.3, 4.0) - 0.1 (-1.8, 2.1) 1.4 (-0.8, 3.6) 
  Women, model 2 3.6 (1.0, 6.2) 1.3 (-1.0, 3.5) - 0.1 (-1.9, 2.1) 1.4 (-0.8, 3.6) 
      
Total body fat (%)      
  Men, model 1 1.7 (0.6, 2.9) 0.0 (-1.0, 1.1) - -0.1 (-1.2, 1.1) -0.1 (-1.2, 1.1) 
  Men, model 2 1.4 (0.3, 2.5) -0.2 (-1.3, 0.8) - -0.1 (-1.2, 0.9) -0.5 (-1.6, 0.7) 
  Women, model 1 2.3 (0.9, 3.6) 0.8 (-0.6, 2.2) - -0.2 (-1.4, 1.0) 0.6 (-0.8, 1.9) 
  Women, model 2 1.9 (0.6, 3.3) 0.5 (-0.9, 1.8) - -0.2 (-1.5, 1.1) 0.5 (-0.9, 1.9) 
Results are presented as the mean differences (with 95% confidence interval) compared with the reference group, and based on analyses 
weighted towards the BMI distribution of the general population (n=5094; 2449 men and 2645 women). Model 1, crude model. Model 2, 
adjusted for age, physical activity, education, ethnicity, use of hypnotics and sedatives, alcohol consumption, coffee consumption and smoking. 
Analyses in women were additionally adjusted for menopausal status and use of hormones.  
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Table 3: Associations between sleep quality and BMI, WC and TBF in 5094 participants in the NEO study aged between 45 and 65 years. 
 Reference 
(PSQI ≤5) 
Poor sleep quality 
(PSQI >5) 
Worse sleep quality 
PSQI ≥8 
Body mass index (kg/m2)    
  Men, model 1 - 0.7 (0.3, 1.2) 0.8 (0.1, 1.4) 
  Men, model 2 - 0.7 (0.2, 1.1) 0.7 (0.1, 1.3) 
  Women, model 1 - 0.8 (0.4, 1.2) 1.1 (0.6, 1.6) 
  Women, model 2 - 0.6 (0.1, 1.0) 0.8 (0.3, 1.3) 
    
Waist circumference (cm)    
  Men, model 1 - 2.5 (1.2, 3.8) 2.6 (0.7, 4.4) 
  Men, model 2 - 2.3 (1.1, 3.6) 2.5 (0.7, 4.3) 
  Women, model 1 - 1.8 (0.6, 3.1) 2.7 (1.1, 4.2) 
  Women, model 2 - 1.2 (-0.0, 2.4) 1.9 (0.4, 3.4) 
    
Total body fat (%)    
  Men, model 1 - 1.1 (0.4, 1.8) 1.3 (0.3, 2.3) 
  Men, model 2 - 1.0 (0.3, 1.8) 1.2 (0.3, 2.2) 
  Women, model 1 - 1.1 (0.4, 1.8) 1.7 (0.8, 2.5) 
  Women, model 2 - 0.8 (0.1, 1.5) 1.2 (0.4, 2.1) 
Results are presented as the mean differences (with 95% confidence interval) compared with the reference group, and based on analyses 
weighted towards the BMI distribution of the general population (n=5094; 2449 men and 2645 women). Model 1, crude model. Model 2, 
adjusted for age, physical activity, education, ethnicity, alcohol consumption, coffee consumption and smoking. Women are additionally 
adjusted for menopausal status and use of hormones. Reference group, 61.2% women, 76.4% men; PSQI>5, 38.9% women, 23.6% men; 
PSQI≥8, 21.7% women, 11.2% men.  
Supplement Table 1: Characteristics of 1,947 participants who underwent MRI and 
completed the PSQI questionnaire in the NEO study, and stratified by sex. 






Age (years) 56 (6) 55 (6) 55.9 (6) 
BMI (kg/m2) 26 (4) 25 (4) 26.4 (3) 
Total body fat (%) 30 (8) 35.7 (6) 24.3 (5) 
Waist circumference (cm) 90 (12) 84 (12) 97 (10) 
VAT (cm2)  76 (47, 116) 54 (36, 84) 101.4 (73, 140) 
Total sleep-duration (hours/night) 7 (1) 7 (1) 7 (1) 
Pittsburgh score 4 (3, 6) 5 (3, 7) 4 (2, 5) 
Education (% high a) 47 ± 1.1 43 ± 1.6 51 ± 1.6 
Ethnicity (% white) 96 ± 0.4 95 ± 0.7 96 ± 0.6 
Alcohol consumption (g/day) 10 (3, 21) 8 (2, 15) 17 (5, 28) 
Physical activity (MET-hours/week) 31 (16, 52) 30 (16, 51) 32 (16, 54) 
Coffee consumption b 
- 0 cups/day 
- >0-4 cups/day 
- >4 cups/day 
 
5 ± 0.5 
59 ± 1.1 
37 ± 1.1 
 
7 ± 0.8 
66 ± 1.6 
27 ± 1.5 
 
2 ± 0.4 
51 ± 1.6 





14 ± 0.8 
46 ± 1.3 
 
13 ± 1.1 
45 ± 1.6 
 
15 ± 1.1 
46 ± 1.6 
Use of hypnotics and sedatives 3 ± 0.4 4 ± 0.6 2 ± 0.4 







9 ± 0.9  




Post-menopausal state (%) - 58 ± 1.6 - 
Results were based on analyses weighted towards the BMI distribution of the general 
population  (n=1947; 1032 men, 915 women). Data are shown as mean (SD), median (IQR) or 
percentage ± 95% confidence interval for measurement dispersion. 
BMI: Body Mass Index; MET: metabolic equivalent; NEO: Netherlands Epidemiology of 
Obesity; VAT: visceral adipose tissue; SAT: abdominal subcutaneous adipose tissue. 
a High education: High education: higher general secondary education, pre-university 
education, higher vocational education, university. 
b Coffee cup defined as 125 ml/cup. 






Supplementary Table 2: Associations between sleep duration and BMI, WC and TBF in 1,947 participants in the NEO study aged between 45 and 65 
years. The study population is grouped according to sleep duration 
 Shortest sleep 
(0-10%) 
Men = 1.7-5.7 hrs 
Women = 2.9-5.4 hrs 
Short sleep 
(10-20%) 
Men = 5.7-6.0 hrs 
Women = 5.4-5.9 hrs 
Reference  
(20-80%) 
Men = 6.0-7.7 hrs 
Women = 5.9-7.9 hrs 
Long sleep  
(80-90%) 
Men = 7.7-8.0 hrs 
Women = 7.9-8.0 hrs 
Longest sleep 
(90-100%) 
Men = 8.0-10.8 hrs 
Women = 8.0-10.9 hrs 
Body mass index (kg/m2)      
   Men, model 1 1.2 (0.3, 2.1) -0.6 (-1.5, 0.4) - -0.1 (-0.9, 0.8) -0.6 (-1.6, 0.3) 
   Men, model 2 1.2 (0.2, 2.1) -0.7 (-1.6, 0.3) - -0.0 (-0.8, 0.8) -0.9 (-1.8, 0.1) 
   Women, model 1 1.7 (-0.3, 3.1) 0.5 (-0.8, 1.7) - -0.4 (-1.4, 0.5) 0.4 (-0.8, 1.6) 
   Women, model 2 1.4 (-0.2, 2.7) 0.3 (-0.9, 1.4) - -0.4 (-1.3, 0.5) 0.1 (-1.1, 1.4) 
      
Waist circumference (cm)      
   Men, model 1 4.7 (2.2, 7.2) -0.2 (-2.8, 2.3) - 0.4 (-2.5, 3.3) -1.0 (-3.8, 1.7) 
   Men, model 2 4.4 (2.0, 6.9) -1.0 (-3.6, 1.6) - 0.3 (-2.4, 3.0) -1.9 (-4.7, 0.9) 
   Women, model 1 3.4 (-0.7, 7.6) 2.4 (-0.6, 5.4) - 0.0 (-2.9, 2.9) 1.3 (-1.9, 4.5) 
   Women, model 2 2.5 (-1.4, 6.5) 1.4 (-1.6, 4.4) - 0.0 (-2.9, 3.0) 0.8 (-2.6, 4.3) 
      
Total body fat (%)      
   Men, model 1 1.3 (-0.1, 2.8) -0.3 (-1.7, 1.1) - -0.0 (-1.5, 1.5) -1.2 (-2.8, 0.3) 
   Men, model 2 1.3 (-0.1, 2.7) -0.8 (-2.3, 0.6) - -0.1 (-1.4, 1.2) -1.6 (-3.2, -0.0) 
   Women, model 1 1.6 (-0.8, 4.0) 0.4 (-1.5, 2.3) - -0.3 (-2.2, 1.7) -0.1 (-2.1, 1.9) 
   Women, model 2 1.2 (-1.0, 3.4) -0.0 (-1.8, 1.8) - -0.4 (-2.4, 1.6) -0.4 (-2.5, 1.7) 
Results were based on analyses weighted towards the BMI distribution of the general population (n=1947; 1032 men, 915 women) and are 
presented as the mean differences (with 95% confidence interval) compared with the reference group. Model 1, crude. Model 2, adjusted for age, 
physical activity, education, ethnicity, use of hypnotics and sedatives, alcohol consumption, coffee consumption and smoking. Models in women 
were additionally adjusted for menopausal status and use of hormones.  
Supplementary Table 3: Associations between sleep-quality and BMI, WC and TBF in 1,947 participants in the NEO study aged between 45 
and 65 years. The study population is grouped according to PSQI score. 
 Reference 
(PSQI ≤5) 
Poor sleep quality 
(PSQI >5) 
Worse sleep quality 
PSQI ≥8 
Body mass index (kg/m2)    
   Men, model 1 - 1.1 (0.5, 1.6) 0.8 (0.0, 1.6) 
   Men, model 2 - 1.0 (0.4, 1.6) 0.8 (0.1, 1.6) 
   Women, model 1 - 1.3 (0.7, 1.9) 1.5 (0.7, 2.3) 
   Women, model 2 - 1.2 (0.6, 1.8) 1.5 (0.7, 2.2) 
    
Waist circumference (cm)    
   Men, model 1 - 3.5 (1.7, 5.3) 2.2 (-0.1, 4.6) 
   Men, model 2 - 3.4 (1.6, 5.1) 2.2 (-0.2, 4.6) 
   Women, model 1 - 3.1 (1.2, 5.0) 3.8 (1.4, 6.2) 
   Women, model 2 - 2.6 (0.7, 4.4) 3.2 (0.9, 5.6) 
    
Total body fat (%)    
   Men, model 1 - 1.5 (0.5, 2.5) 1.0 (-0.3, 2.3) 
   Men, model 2 - 1.5 (0.5, 2.5) 1.1 (-0.2, 2.4) 
   Women, model 1 - 1.7 (0.5, 2.8) 2.1 (0.6, 3.6) 
   Women, model 2 - 1.4 (0.3, 2.5) 1.9 (0.4, 3.3) 
Results were based on analyses weighted towards the BMI distribution of the general population (n=1947; 1032 men, 915 women). Results are 
presented as the mean differences (with 95% confidence interval) compared to the reference group. Model 1, crude. Model 2, adjusted for age, 
physical activity, education, ethnicity, alcohol consumption, coffee consumption and smoking. Models in women were additionally adjusted for 
menopausal status and use of hormones. Reference group, 65.5% women, 77.5% men; PSQI>5, 34.5% women, 22.5% men; PSQI≥8, 19.8% 
women, 10.9% men.  
